Free Trading + Demat Account

Vanta Bioscience Ltd IPO (Vanta Bioscience IPO) Detail

Sep 25, 2017 - Sep 27, 2017

Incorporated in 1995, Vanta Bioscience Ltd (VBL) is a preclinical contract research company whhich offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.

In addition they also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachable including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBL also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation.

One of the major services of VBL is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Toxicology and safety assessment are sometimes used interchangeably and considered as synonymous.

Vanta Bioscience based in Des Moines, Iowa with additional offices in Brussels, Belgium; and West Des Moines, Iowa. It has a toxicology research facility in Chennai, India.

Company Promoters:

The promoters of the company are:

1. Mohan Krishna Mulakala,
2. Dopesh Raja Mulakala,
3. Dr Vyasmurti Madhavrao Shingatgeri,
4. Dr. Soumya Simhadri,
5. Shravan Chintapatla,
6. Karishma Mulakala,
7. Sajan Kiran Mulakala,
8. Pradeep Chowdary and
9. Dr. Chandrasekhar Rao Simhadri

Objects of the Issue:

The objects of the Net Proceeds of the Issue are:

1. Augmenting additional working capital requirements;
2. General Corporate Purposes.

Vanta Bioscience IPO Details

Issue OpenSep 25, 2017 - Sep 27, 2017
Issue TypeFixed Price Issue IPO
Issue Size1,512,000 Eq Shares of Rs 10
(aggregating up to Rs 7.56 Cr)
Face ValueRs 10 Per Equity Share
Issue PriceRs 50 Per Equity Share
Market Lot3000 Shares
Min Order Quantity3000 Shares
Listing AtBSE SME

Vanta Bioscience IPO Subscription Status (Bidding Detail)

Vanta Bioscience IPO how much subscribed?

No. of Times Issue Subscribed (BSE + NSE)

As on Date & Time







Shares Offered







Sep 27, 2017 17:00

Vanta Bioscience IPO Prospectus

Vanta Bioscience IPO Rating

Rating:Rated 3.7 stars

Vote Here ...

Vanta Bioscience IPO Listing Date

Listing DateFriday, October 6, 2017
BSE Script Code540729
NSE Symbol
Listing InM
Issue PriceRs 50 Per Equity Share
Face ValueRs 10 Per Equity Share

Listing Day Trading Information

Issue Price
Last Trade
Rs 50.00
Rs 51.10
Rs 50.00
Rs 53.85
Rs 50.20

Vanta Bioscience IPO Reviews / Ratings

Company Contact Information

Vanta Bioscience Ltd
NO 02/G/308/G, NO 3/FF/SF/1-20-248 Umajay Complex,
Rasoolpura, Secunderabad,
Hyderabad – 500 003

Phone: +91 40 6657 5454

Vanta Bioscience IPO Registrar

Bigshare Services Pvt Ltd
   1st Floor, Bharat Tin Works Building,
   Opp. Vasant Oasis,Makwana Road,
   Marol, Andheri(E), Mumbai - 400 059

Phone: +91-22-6263 8200

Guaranteed Save 60% to 90% Brokerage

You could reduce the brokerage cost significantly by moving to another stock broker. Our expert team compared top share brokers in India to help traders. STOP paying Demat AMC, Brokerage in %, PCM Fee and High Stamp Duty today.

We can help you choosing the right broker. Contact us today...

Vanta Bioscience IPO Review / Comments

8. LoneRanger  Oct 3, 2017 16:08 I Like It. | Report Abuse
Top Contributor Top Contributor (200+ Posts, 200+ Likes)
Wow, very good response from HNI and QIB.
Hope to list in premium.
8.1. STOCKT  Oct 4, 2017 00:11 I Like It. | Report Abuse
lol where is good response. its in fact very low response
7. ConstrainedEPS  Sep 25, 2017 21:37 I Like It. | Report Abuse
Why there is no info about P&L ? I mean they just acquired this business by paying 12 Cr without bothering about Balance Sheet ?
and now wants to sell it to public for Valuation of 28 Cr ?
I am not able to understand the valuation here ... They atleast could have just provided the past revenue / profit of the company ?
IPO euphoria h toh kuch bhi beecho bc ,.,,
6. GkRaya  Sep 14, 2017 18:42 I Like It. | Report Abuse
It is mentioned that the company is based out of Iowa and Belgium. Company website has Secundarabad and Chennai addresses. Only research center is in Chennai. Is it a foreign based company and entering into Indian market? Regarding GVK, point is already raised in this forum...A clarification requested...
JS Investor
6.1. JS Investor  Sep 20, 2017 16:15 I Like It. | Report Abuse
GVK entered into the agreement but deal couldnt go through. Post that these promoters acquired the facility in the new company and were allowed to use name Vanta by erstwhile US Promoters
5. beingshreyas  Sep 18, 2017 19:34 I Like It. | Report Abuse
avoid this.
4. GkRaya  Sep 14, 2017 18:48 I Like It. | Report Abuse
At the same time, profile is good
3. Rafiq  Sep 14, 2017 13:43 I Like It. 1 | Report Abuse
In simple words GVK company ne is company ko kharida tha 2014 me to yeh company kaise apna share khud bech sakti hai?
2. NPP  Sep 14, 2017 11:03 I Like It. 2 | Report Abuse
Yes ,You are right sir , I have gone through your given Website , When agreement done in 2014 As same your understanding I could not say how this company can sell equity ? If any one help who really guide , Pl help . .......
1. Rafiq  Sep 14, 2017 00:54 I Like It. 2 | Report Abuse

When GVK bioscience signed definitive agreement, how come this company is selling their shares? Can anyone help me to understand.

Message Board

Stock Message Board

Search Mobile Apps:

Download Android App Downlaod iOS App